Here are five key points:
1. The market was valued at $28.99 billion at the end of last year.
2. From 2016 to 2024, the market is projected to increase at a compound annual growth rate of 2.7 percent.
3. The market is anticipated to hit $36.61 billion by 2024.
4. The report notes the market is highly fragmented and comprised of players of many sizes. Major market players include:
•Abbott in Chicago
•Pfizer in New York City
•Merck & Co. in Kenilworth, N.J.
•Bayer in Leverkusen, Germany
5. The Asia-Pacific region will likely experience high growth through 2024.
More articles on quality & infection control:
National Patient Safety Foundation to lead 2017 patient safety awareness week: 5 highlights
5 trends in HAIs
High hand hygiene compliance yields lower HAIs, savings totaling $5M — 4 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
